Literature DB >> 17049511

Airborne particulate matter from primarily geologic, non-industrial sources at levels below National Ambient Air Quality Standards is associated with outpatient visits for asthma and quick-relief medication prescriptions among children less than 20 years old enrolled in Medicaid in Anchorage, Alaska.

Marc-Andre R Chimonas1, Bradford D Gessner.   

Abstract

In Anchorage, Alaska, particulates with aerodynamic diameter < or = 10 micro m (PM(10)) arise primarily from natural, geologic sources, and particulates with aerodynamic diameter < or = 2.5 micro m (PM(2.5)) arise primarily from automobile emissions. The current study used a population-based time-series analysis design to evaluate the effects of daily and weekly PM(10) and PM(2.5) on respiratory health outcomes among children <20 years of age residing in Anchorage enrolled in Medicaid. All generated estimating equations models were adjusted for season, year, weekends, temperature, wind speed, and precipitation. Relative to the days with PM(10) mass concentration < or = 13 micro g/m(3), a significant 9.3% increase (RR: 1.093, 95% CI: 1.004-1.191) in the rate of outpatient visits for asthma occurred during days with PM(10) of 20-33 micro g/m(3). No further dose-response occurred for days with PM(10) > or = 34 micro g/m(3). A significant 18.1% increase (RR: 1.181, 95% CI: 1.010-1.381) in the rate of quick-relief medication prescriptions occurred during days with PM(10) of 34-60 micro g/m(3), and a 28.8% increase (RR: 1.288, 95% CI: 1.026-1.619) occurred during days with PM(10) > or = 61 micro g/m(3). Similar results for outpatient asthma visits and quick-relief medication occurred in weekly models. There were no significant associations with PM(2.5) in either daily or weekly models. These subtle but statistically significant associations suggest that non-industrial, geologic sources of PM(10) may have measurable health effects at levels below current national standards.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049511     DOI: 10.1016/j.envres.2006.08.013

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  6 in total

Review 1.  Clearing the air: a review of the effects of particulate matter air pollution on human health.

Authors:  Jonathan O Anderson; Josef G Thundiyil; Andrew Stolbach
Journal:  J Med Toxicol       Date:  2012-06

2.  Short-term effects of air pollution on wheeze in asthmatic children in Fresno, California.

Authors:  Jennifer K Mann; John R Balmes; Tim A Bruckner; Kathleen M Mortimer; Helene G Margolis; Boriana Pratt; S Katharine Hammond; Frederick W Lurmann; Ira B Tager
Journal:  Environ Health Perspect       Date:  2010-06-22       Impact factor: 9.031

Review 3.  Cold Climate Impact on Air-Pollution-Related Health Outcomes: A Scoping Review.

Authors:  Osnat Wine; Alvaro Osornio Vargas; Sandra M Campbell; Vahid Hosseini; Charles Robert Koch; Mahdi Shahbakhti
Journal:  Int J Environ Res Public Health       Date:  2022-01-28       Impact factor: 3.390

4.  Symptoms and medication use in children with asthma and traffic-related sources of fine particle pollution.

Authors:  Janneane F Gent; Petros Koutrakis; Kathleen Belanger; Elizabeth Triche; Theodore R Holford; Michael B Bracken; Brian P Leaderer
Journal:  Environ Health Perspect       Date:  2009-03-31       Impact factor: 9.031

Review 5.  Association between Air Pollutants and Asthma Emergency Room Visits and Hospital Admissions in Time Series Studies: A Systematic Review and Meta-Analysis.

Authors:  Xue-yan Zheng; Hong Ding; Li-na Jiang; Shao-wei Chen; Jin-ping Zheng; Min Qiu; Ying-xue Zhou; Qing Chen; Wei-jie Guan
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

6.  Long-term PM2.5 exposure and the clinical application of machine learning for predicting incident atrial fibrillation.

Authors:  In-Soo Kim; Pil-Sung Yang; Eunsun Jang; Hyunjean Jung; Seng Chan You; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Jong-Youn Kim; Boyoung Joung
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.